Neurosteroid modulation of GABAergic neurotransmission in the central amygdala: A role for NMDA receptors by Wang, Chunsheng et al.
Neurosteroid Modulation of GABAergic Neurotransmission in the
Central Amygdala: A Role for NMDA Receptors
Chunsheng Wang1,3, Christine E. Marx1,3,5, A. Leslie Morrow6,7, Wilkie A. Wilson2,4,5, and
Scott D. Moore1,3,5
1 Department of Psychiatry and Behavioral Sciences, Duke University Medical Center
2 Department of Pharmacology and Cancer Biology, Duke University Medical Center
3 Division of Psychiatry, Durham Veterans Affairs Medical Center Durham, North Carolina
4 Division of Neurology Research, Durham Veterans Affairs Medical Center Durham, North Carolina
5 VISN 6 Mental Illness Research, Education and Clinical Center, Durham, N.C. 27705
6 Department of Psychiatry, University of North Carolina, Chapel Hill, NC, U.S.A.
7 Department of Pharmacology, University of North Carolina, Chapel Hill, NC, U.S.A.
Abstract
The neurosteroid 3α-hydroxy-5α-pregnan-20-one (allopregnanolone or ALLO) positively modulates
GABAA receptors, an action that may contribute to the anxiolytic effects of ALLO. Recent evidence
suggests that ALLO’s anxiolytic effects appear to be mediated by the amygdala, a key neural structure
for emotional and cognitive behaviors. However, little is known regarding ALLO effects on
amygdala physiology. We therefore explored ALLO effects on GABA neurotransmission in the
central nucleus (Ce) of the amygdala, a major output nucleus involved in fear and anxiety. We
recorded evoked GABAA receptor-mediated inhibitory postsynaptic currents (IPSCs) in Ce neurons
using whole-cell patch clamp techniques. We observed that ALLO significantly reduced the
amplitude of evoked GABAA receptor-mediated IPSCs. However, the effect of ALLO was occluded
by the NMDA receptor antagonist D-APV. D-APV alone also reduced evoked IPSCs in Ce neurons.
These results suggest that ALLO-induced reduction of GABAergic transmission in Ce appears to
depend on neural network activity, possibly involving an NMDA receptor-mediated mechanism.
These ALLO effects on GABAergic transmission in the central amygdala may play a role in
mediating its anxiolytic actions.
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Introduction
Neurosteroids are molecules formed de novo in the brain that modulate both inhibitory and
excitatory neurotransmission (Rupprecht and Holsboer 1999). The neurosteroid
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allopregnanolone (ALLO) enhances γ-aminobutyric acid type A (GABAA) receptor-mediated
Cl− current (Majewska et al, 1986; Morrow et al, 1987, 1990), an action that may contribute
to its anxiolytic effects (Crawley et al, 1986; Wieland et al, 1991). Allopregnanolone levels in
plasma and brain increase rapidly following acute stress (Purdy et al. 1991; Barbaccia et al.
1996, Morrow et al 1998). ALLO elevations have also been observed following antidepressant
(Guidotti and Costa, 1998; Uzunova et al., 1998) and antipsychotic (Marx et al. 2003; Barbaccia
et al 2001) administration.
The amygdala formation is a complex structure containing multiple subnuclei and pathways
(Pitkänen 2000). The central nucleus (Ce) is a major output nucleus of the amygdala that may
directly mediate anxiety and the anxiolytic effects of a number of pharmacologic compounds
(Roberto et al 2003, Delaney and Sah 1999, Kang-Park et al 2004). In addition, direct
application of ALLO to Ce causes marked anxiolytic effects in rats (Akwa et al., 1999),
suggesting that anxiolytic effects of ALLO may be mediated by the amygdala.
Electrophysiological characteristics of ALLO effects have been studied using patch clamp
techniques with different cell preparations in a variety of CNS regions in rats (Poisbeau et al
1997; Fáncsik et al 2000; Haage et al 1999, 2002, Uchida et al 2002; Brussaard et al 1999;
Sooksawate and Simmonds 1998; Puia et al 2003). These studies examined GABAA receptor-
mediated miniature inhibitory postsynaptic currents (mIPSCs) or GABA evoked currents
through bath application of GABA. The consistent finding in these efforts has been that ALLO
positively modulates GABAA receptors by significantly prolonging the Cl− channel open time,
allowing more Cl− influx into neurons through GABAA receptor channels. However, little is
known regarding ALLO effects on electrically evoked GABA responses involving a specific
neural network. We therefore explored ALLO effects on the electrophysiology of GABAergic
transmission in Ce.
Materials and Methods
All experimental procedures were in accordance with the NIH Guide for the Care and Use of
Laboratory Animals. Male rats (Sprague Dawley, 3–5 weeks) were deeply anesthetized with
halothane and quickly decapitated. The brains were removed, blocked, and sliced in the coronal
plane with a vibratome. Slices (300 μm thick) containing the mid-caudal amygdala formation
(Bregma −2.30 to −2.80 mm) were incubated at room temperature in artificial cerebrospinal
fluid (ACSF) composed of (in mM): NaCl, 124; dextrose, 10; NaHCO3, 26; KCl, 2;
KH2PO4, 1.25; CaCl2, 2; and MgSO4, 1; and equilibrated with 95% O2 and 5% CO2.
After 1-hour incubation, slices were transferred into an immersion-type recording chamber at
room temperature continuously perfused with oxygenated ACSF at a rate of 3 ml/min. All
experiments were conducted at room temperature (27 °C). For studies of synaptic transmission,
patch pipettes were filled with intracellular solution A containing (in mM): Cs-gluconate, 130;
CsCl, 7; HEPES, 10; Mg-ATP, 4; Tris-GTP, 0.5, QX-314, 4. For membrane property
recordings, patch pipettes were filled with intracellular solution B containing (in mM): K-
gluconate, 130; KCl, 7; HEPES, 10; Mg-ATP, 4; Tris-GTP, 0.5. The intracellular solutions
were adjusted to a pH of 7.2–7.3 with KOH (or CsOH) and to an osmolarity of 280–290 mOsm.
Pipette resistances were 3–6 MΩ. Intracellular recordings neurons within Ce visualized with
a light microscope (Fig. 1a) (Axioskop 2, Carl Zeiss) with a water immersion lens (40X, Zeiss)
(Wang et al. 2003). Once a giga-seal was obtained upon a neuron, a gentle suction was applied
to the recordings pipette to cause the cell membrane to rupture, achieving the whole-cell
configuration. Electrical signal were amplified through an Axopatch 200B amplifier (Axon
Instruments, Foster City, CA). The junction potential was offset to zero just before approaching
to the cell. All of the cells used in the study had a resting membrane potential below −55 mV
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and access resistance less than 30 MΩ. Access resistance was monitored throughout recordings,
and cells were rejected if it changed by more than 15% during the experiment.
IPSCs were electrophysiologically isolated with the cell membrane potential held at the
reversal potential for glutamatergic currents (0 mV) in voltage-clamp mode. For evoked IPSC
recordings, single stimuli were delivered every 40 seconds through a unipolar tungsten
microelectrode placed in the core of the central nucleus of the amygdala. Stimulating intensity
(ranged from 15 to150 μA, 200 μsec duration) was individually adjusted to be half current
intensity needed to trigger the maximum eIPSC amplitude. For membrane property recordings,
cell membrane potentials were held under current-clamp mode. Electrical signals were
recorded and analyzed with a self-developed software using Labview (National Instruments,
Austin, TX). Peak amplitude of evoked responses was measured and compared before and after
drug application using paired student’s t-test and one-way ANOVA.
3α-Hydroxy-5α-pregnan-20-one (allopregnanolone) (Steraloids Inc. Newport, RI) was first
dissolved into DMSO (1 mM) and then diluted into ACSF. D-(−) 2-amino-5-phosphonovaleric
acid (D-APV) (Fisher) was dissolved in water to make a stock solution (40 mM). Picrotoxin
(Sigma) was directly dissolved into ACSF. 6,7-Dinitroquinoxaline-2,3 (1H, 4H)-dione
(DNQX) (Sigma) was prepared as a stock solution in DMSO (0.2 M). TTX in citrate buffer
(Sigma) was prepared as a stock solution (1 mM). ATP, GTP, and lidocaine N-ethyl bromide
(QX-314) were directly dissolved into the intracellular pipette solution. In experiments using
compounds dissolved in DMSO, the same concentration of DMSO was used in control ACSF.
Results
We first examined ALLO effects on membrane properties of Ce neurons. Ce neurons were
recorded in current clamp mode with intracellular solution B (see methods). The average resting
membrane potential in Ce neurons was −67.6 ± 1.2 mV in control conditions and −67.7 ± 1.3
mV after bath application of ALLO (100 nM), with no significant change (n = 8). The input
resistance of Ce neurons was 262 ± 33 MΩ before and 275 ± 38 MΩ after ALLO (n = 8). ALLO
did not change the current-voltage (I-V) relationship in Ce neurons. Neurons showed a wide
range in the number of spikes in response to a depolarizing current injection (150 pA, 600ms)
ranging from 2 to 18. All neurons recorded in current clamp mode in Ce (n = 8) showed spike
accommodation and the pattern of spike accommodation was very similar before and after
ALLO application. These results indicate that membrane properties of Ce neurons are not
altered by ALLO.
To examine GABAergic transmission in the central amygdala, we recorded evoked IPSCs
(eIPSCs) in Ce neurons in response to stimulation at the lateral margin of Ce. We first confirmed
that the reversal potential of the eIPSC was between −65 and −70 mV in Ce neurons (Fig. 1a).
However, to evaluate the possibility that ALLO was having effects on intact neural networks,
we subsequently isolated IPSCs using a holding potential of 0 mV (near the reversal potential
for the glutamate receptor-mediated responses). As shown in Fig. 1b, picrotoxin (PTX, 100
μM, a GABAA receptor channel blocker) completely blocked the eIPSCs, with little residual
current remaining from potential excitatory postsynaptic currents (including NMDA or AMPA
currents). These data demonstrate that the recorded eIPSCs reflect a relatively pure GABAergic
current.
After bath application of ALLO at a physiological concentration (100 nM), the amplitude of
eIPSCs in Ce neurons was significantly reduced, with an average reduction of 31.0 ± 4.0% (n
= 8, p< 0.01, paired t-test, Fig. 1c, d). In general, we saw no reversal of the ALLO effect upon
re-superfusion with control medium up to 30 minutes (n=4). No rundown of the eIPSCs was
observed in the recorded neurons in control conditions. Since ALLO is known to directly
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enhance GABAA receptor function in other systems involving dissociated neurons (Poisbeau
et al 1997; Haage et al 1999; Sooksawate and Simmonds 1998), we determined if ALLO-
induced decreases in GABAergic transmission in Ce depend on neural network activities.
To further investigate possible involvement of glutamate in the mechanism of ALLO-induced
reduction of GABAergic transmission, we examined the role of NMDA receptors in ALLO
actions on GABAergic transmission in Ce. To test this possibility, the NMDA receptor
antagonist D-APV (50 μM) was applied to the amygdala slice preparation. As shown in Fig.
2, D-APV occluded the reduction of eIPSCs in Ce neurons by ALLO (n = 7, p > 0.05, paired
t-test). This result suggests that NMDA receptor function is relevant to ALLO reduction of
GABAergic transmission in Ce.
If ALLO-induced reduction of GABAergic transmission is mediated by the negative
modulation of NMDA receptors, we would expect a reduction of GABAergic transmission by
NMDA blockers such as D-APV. We tested this possibility by applying the NMDA receptor
antagonist D-APV (50 μM) to the amygdala slice preparation. As shown in Fig. 3, D-APV
significantly reduced the eIPSC in Ce neurons by 46 ± 8% (n = 7, p < 0.01, paired t-test).
In cingulate cortex inhibition of NMDA receptor-mediated functions causes a reduction of
GABAergic transmission (Li et al 2002). We reasoned that ALLO may be suppressing NMDA-
mediated functions in Ce neurons, and therefore examined ALLO effects on evoked NMDA-
mediated currents. NMDA currents were observed at a holding potential of +40 mV in
conjunction with application of PTX (100 μM) and DNQX (20 μM, an AMPA receptor
antagonist) in the bath (Fig. 4). Our results showed a small but significant reduction (12 ± 2%;
n = 11, p< 0.05, one-way ANOVA) of NMDA current (D-APV sensitive) in Ce neurons in the
presence of ALLO (100 nM) (Fig. 4). When ALLO concentration was increased to 4 μM, the
average reduction of NMDA current was 14 ± 4% of ALLO (n = 5, p< 0.05, one-way
ANOVA). There was no significant difference between the two concentrations.
Discussion
In this study, we explored the electrophysiological effects of ALLO on GABAergic
neurotransmission in the central amygdala. Specifically, ALLO negatively modulates eIPSCs,
in contrast to previous studies of ALLO effects on mIPSCs in different brain regions (Poisbeau
et al 1997; Haage and Johansson 1999; Patenaude et al 2001). Unlike mIPSCs, eIPSCs involve
membrane excitability and network functioning. However, our results revealed that ALLO did
not significantly affect membrane properties of Ce neurons. This left the possibility that other
neural network effects of ALLO may underlie the mechanism of ALLO-induced reduction of
evoked GABAergic transmission in Ce. As shown previously, glutamatergic NMDA receptors
have significant effects on GABAergic transmission in CNS neurons (Aguayo et al. 1998; Li
et al. 2002). Specifically, these prior studies demonstrated that activation of NMDA receptors
enhances GABAergic transmission, whereas blocking NMDA receptors reduces GABAergic
transmission. We therefore examined the effects of the NMDA receptor antagonist D-APV on
the ability of ALLO to suppress eIPSCs. Both ALLO and D-APV reduced evoked IPSCs in
Ce, and D-APV prevented further reduction of eIPSCs by ALLO. These results suggest that
the effects of ALLO on eIPSCs possibly involve an NMDA receptor-mediated mechanism.
Although the direct inhibitory effect on ALLO on isolated NMDA receptor-mediated currents
was relatively modest compared to ALLO effects on eIPSCs, we speculate that this could be
due to amplication of ALLO effects in an intact, complex network.
Since inhibition of NMDA receptor function occluded ALLO-induced reduction of eIPSCs,
we suggest that an NMDA receptor-dependent mechanism may mediate ALLO effects on
GABA neurotransmission in Ce. However, the concentration of GABA has also been shown
Wang et al. Page 4













to play a role in ALLO effects on GABAA receptors in rat hypothalamic cultured neurons
(Poisbeau et al 1997) and dissociated medial preoptic neurons (Haage and Johansson 1999).
Specifically, at low GABA concentrations, ALLO potentiates GABAA receptor responses, but
has no effect or significantly decreases GABAA receptor responses at high GABA
concentrations. The exact mechanism for this phenomenon is not clear, but it has been
suggested that changes in kinetic properties of the GABAA receptor channel and desensitization
of GABAA receptors by ALLO may be involved (Haage and Hohansson 1999). In our
experiments, electrical stimulation of GABAergic neurons in Ce would likely cause a large
amount of GABA release and significantly elevate the concentration of GABA, potentially
leading to a change in the way of effects of ALLO on GABAA receptor-mediated responses.
In addition, GABA receptor desensitization in high concentrations of ALLO has been
demonstrated previously (Haage and Hohansson 1999). However, this may not fully explain
our results. Moreover, this explanation is inconsistent with the suppression of eIPSCs by the
NMDA antagonist D-APV and the subsequent occlusion of the ALLO effect.
The possibility that NMDA receptors contribute to the effects of ALLO is supported by the
finding that ALLO decreases NMDA receptor-mediated current in Ce neurons. Although direct
ALLO effects on NMDA receptors have not been reported previously, prior studies have shown
that the sulfated ALLO stereoisomer pregnanolone sulfate (3α-hydroxy-5β-pregnan-20-one
sulfate or PS) negatively modulates NMDA current in different cell types (Irwin et al 1994;
Park-Chung et al 1994, Weaver et al 2000), as does its synthetic homologue pregnanolone
hemisuccinate (Weaver et al 1997). The exact mechanism(s) of possible ALLO regulation of
NMDA receptor-dependent processes remains unclear.
Our data provide an initial electrophysiological exploration of ALLO effects on GABA and
NMDA receptor-mediated neurotransmission in the Ce, and raise the possibility that NMDA
receptors play an important role in ALLO actions. These results also suggest that ALLO effects
on GABAergic transmission in a neural network may be different from effects on isolated
neurons. These findings may provide insights into potential mechanisms mediating ALLO’s
pronounced anxiolytic effects, and to the pathophysiology of psychiatric disorders with anxiety
components.
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Figure 1. Allopregnanolone significantly reduces GABAergic transmission in Ce
a). Traces of the evoked inhibitory postsynaptic current (eIPSC) recorded from a Ce neuron
under voltage-clamp mode and in the presence of DNQX (20 μM) and D-APV (50 μM). eIPSCs
at different holding potentials show a reversal potential between −60 to −70 mV. b). The eIPSC
is PTX sensitive, and when held at 0 mV without glutamate receptors blockers, has virtually
no contamination from other sources (such as the EPSC). c). Traces from another Ce neuron
show a reduction of the eIPSC after allopregnanolone (100 nM). This effect could not be
washed off after 30 min of washing. Each trace was an average of 10 consecutive responses
under the same condition. d). Bar graph of the averaged results shows a significant inhibition
of 31.0 ± 4.0% by ALLO. ** p < 0.01 (paired t-test).
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Figure 2. D-APV prevents reduction of GABAergic transmission by ALLO in Ce
Left: superimposed traces of eIPSCs from a Ce neuron before and after ALLO (100 nM)
application in the presence of D-APV (50 μM). Each tracing represents an average of 10
responses in the same condition. Right: Averaged data of 7 neurons shows no significant
inhibition of eIPSC by ALLO in the presence of D-APV
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Figure 3. D-APV significantly reduces GABAergic transmission (eIPSCs) in Ce
a). Superimposed GABAergic responses in a Ce neuron before and after D-APV (50 μM). b).
Averaged results show a significant decrease of peak amplitude of eIPSC after D-APV, ** p
< 0.01, paired t-test.
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Figure 4. Allopregnanolone significantly reduces NMDA (N-methyl-D-aspartate) current in Ce
neurons
Left: superimposed traces of NMDA currents in control and ALLO (100 nM) conditions in a
Ce neuron. NMDA currents were isolated by application of PTX (100 μM) and DNQX (20
μM) with a holding potential at +40 mV during the recording. Because DNQX blocks excitatory
transmission in neural network, NMDA currents were generated by local stimulation within
Ce. This current was blocked by the NMDA receptor blocker D-APV (50 μM). Each trace
represents an average of 10 responses under the same conditions. Right: Averaged data
demonstrates that ALLO (100 nM and 4μM) significantly reduces of the peak amplitude of the
evoked NMDA current by 13 ± 2% (n = 11, p < 0.05, one-way ANOVA) and 14 ± 4% (n = 5,
p < 0.05, one-way ANOVA), respectively. There is no significant difference in reduction of the
peak amplitude of NMDA current between the two ALLO concentrations.
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